SCHEMBL1209722

SCHEMBL1209722

CC(=O)OC1CCc2c(sc(NC(=O)CC(C)c3cccnc3)c2C#N)C1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 10/20 0.46
LMNA P02545 3/20 0.46
GAA P10253 2/20 0.46
ALDH1A1 P00352 8/20 0.43
RAB9A P51151 4/20 0.43
MEN1 O00255 4/20 0.43
KMT2A Q03164 4/20 0.43
POLB P06746 3/20 0.43
RECQL P46063 1/20 0.43
NPC1 O15118 3/20 0.42
L3MBTL1 Q9Y468 2/20 0.42
ESR1 P03372 1/20 0.41
OPRK1 P41145 1/20 0.41
ESR2 Q92731 1/20 0.41
HTT P42858 3/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
ALOX15 P16050 1/20 0.41
MAPK1 P28482 1/20 0.41
TP53 P04637 1/20 0.41
MCL1 Q07820 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1209712 0.90 ALDH1A1 (0.50) MAPTGAAALDH1A1RAB9AMEN1
SCHEMBL1207350 0.90 MAPT (0.44) MAPTLMNAGAAALDH1A1RAB9A
SCHEMBL1207673 0.88 ALDH1A1 (0.46) MAPTLMNAGAAALDH1A1RAB9A
SCHEMBL1209607 0.88 MAPT (0.49) MAPTLMNAGAAALDH1A1RAB9A
SCHEMBL1208313 0.86 MAPT (0.41) MAPTLMNAGAAALDH1A1RAB9A
SCHEMBL1208109 0.86 MAPT (0.48) MAPTLMNAGAAALDH1A1RAB9A
SCHEMBL1208759 0.86 GCGR (0.45) MAPTLMNAGAAALDH1A1RAB9A
SCHEMBL1208761 0.85 L3MBTL1 (0.49) MAPTLMNAGAAALDH1A1RAB9A
SCHEMBL1207394 0.85 ALDH1A1 (0.48) MAPTGAAALDH1A1RAB9AMEN1
SCHEMBL1209160 0.85 MAPT (0.47) MAPTLMNAGAAALDH1A1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110044938-A1 TETRAHYDROBENZOTHIOPHENE DERIVATIVES NYCOMED GMBH (DE) 2011-02-24 US disclosed
EP-2051974-A1 TETRAHYDROBENZOTHIOPHENE DERIVATIVES 4SC AG (DE) 2009-04-29 EP disclosed
WO-2008020045-A1 TETRAHYDROBENZOTHIOPHENE DERIVATIVES 4SC AG (DE) 2008-02-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110044938-A1 TETRAHYDROBENZOTHIOPHENE DERIVATIVES BAX, BCL2, BAD MAPT 865/4885LMNA 3666/4885GAA 3689/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.